D. E. Shaw & Co., Inc. Mustang Bio, Inc. Transaction History

D. E. Shaw & Co., Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.58 - $1.13 $254,215 - $495,282	-438,303 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.73 - $1.81 $96,192 - $238,503	131,770 Added 42.99%	438,303 $443,000
Q4 2021 Feb 14, 2022	BUY	$1.66 - $2.64 $318,965 - $507,270	192,148 Added 167.98%	306,533 $509,000
Q3 2021 Nov 15, 2021	BUY	$2.58 - $3.36 $124,159 - $161,696	48,124 Added 72.63%	114,385 $308,000
Q2 2021 Aug 16, 2021	BUY	$2.7 - $3.81 $178,904 - $252,454	66,261 New	66,261 $220,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $20M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.